A Study of QLS31905 in Patients With Advanced Solid Tumors

Clinical trial NCT05278832 · UNKNOWN

Trial details

NCT number: NCT05278832
Sponsor: Qilu Pharmaceutical Co., Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumors

Start date: 2021-10-25
Primary completion: 2022-12-31
Enrollment: 104

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.